Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

C.S. Storm; D.A. Kia; M.M. Almramhi; S. Bandrés-Ciga; C. Finan; A.J. Noyce; R. Kaiyrzhanov; B. Middlehurst; M. Tan; H. Houlden; H.R. Morris; H. Plun-Favreau; P. Holmans; J. Hardy; D. Trabzuni; J. Quinn; V. Bubb; K.Y. Mok; K.J. Kinghorn; P. Lewis; S.R. Schreglmann; R. Lovering; L. R’Bibo; C. Manzoni; M. Rizig; M. Ryten; S. Guelfi; V. Escott-Price; V. Chelban; T. Foltynie; N. Williams; K.E. Morrison; C. Clarke; K. Harvey; B.M. Jacobs; A. Brice; F. Danjou; S. Lesage; J-C Corvol; M. Martinez; C. Schulte; K. Brockmann; J. Simón-Sánchez; P. Heutink; P. Rizzu; M. Sharma; T. Gasser; S.A. Schneider; M.R. Cookson; C. Blauwendraat; D.W. Craig; K. Billingsley; M.B. Makarious; D.P. Narendra; F. Faghri; J.R. Gibbs; D.G. Hernandez; K. Van Keuren-Jensen; J.M. Shulman; H. Iwaki; H.L. Leonard; M.A. Nalls; L. Robak; J. Bras; R. Guerreiro; S. Lubbe; T. Troycoco; S. Finkbeiner; N.E. Mencacci; C. Lungu; A.B. Singleton; S.W. Scholz; X. Reed; R.J. Uitti; O.A. Ross; F.P. Grenn; A. Moore; R.N. Alcalay; Z.K. Wszolek; Z. Gan-Or; G.A. Rouleau; L. Krohn; K. Mufti; J.J. van Hilten; J. Marinus; A.D. Adarmes-Gómez; M. Aguilar; I. Alvarez; V. Alvarez; F.J. Barrero; J.A.B. Yarza; I. Bernal-Bernal; M. Blazquez; M. Bonilla-Toribio; J.A. Botía; M.T. Boungiorno; D. Buiza-Rueda; A. Cámara; F. Carrillo; M. Carrión-Claro; D. Cerdan; J. Clarimón; Y. Compta; M. Diez-Fairen; O. Dols-Icardo; J. Duarte; R. Duran; F. Escamilla-Sevilla; M. Ezquerra; C. Feliz; M. Fernández; R. Fernández-Santiago; C. Garcia; P. García-Ruiz; P. Gómez-Garre; M.J.G. Heredia; I. Gonzalez-Aramburu; A.G. Pagola; J. Hoenicka; J. Infante; S. Jesús; A. Jimenez-Escrig; J. Kulisevsky; M.A. Labrador-Espinosa; J.L. Lopez-Sendon; A.L. de Munain Arregui; D. Macias; I.M. Torres; J. Marín; M.J. Marti; J.C. Martínez-Castrillo; C. Méndez-del-Barrio; M.M. González; M. Mata; A. Mínguez; P. Mir; E.M. Rezola; E. Muñoz; J. Pagonabarraga; P. Pastor; F.P. Errazquin; T. Periñán-Tocino; J. Ruiz-Martínez; C. Ruz; A.S. Rodriguez; M. Sierra; E. Suarez-Sanmartin; C. Tabernero; J.P. Tartari; C. Tejera-Parrado; E. Tolosa; F. Valldeoriola; L. Vargas-González; L. Vela; F. Vives; A. Zimprich; L. Pihlstrom; M. Toft; P. Taba; S. Kõks; S. Hassin-Baer; K. Majamaa; A. Siitonen; P. Tienari; N.U. Okubadejo; O.O. Ojo; C. Shashkin; N. Zharkinbekova; V. Akhmetzhanov; G. Kaishybayeva; A. Karimova; T. Khaibullin; T.L. Lynch; A.D. Hingorani; N.W. Wood

doi:10.1038/s41467-021-26280-1

Back

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

Journal article

Open access

Peer reviewed

Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

C.S. Storm, D.A. Kia, M.M. Almramhi, S. Bandrés-Ciga, C. Finan, A.J. Noyce, R. Kaiyrzhanov, B. Middlehurst, M. Tan, H. Houlden, …

Nature Communications, Vol.12(1), Art. 7342

2021

DOI: https://doi.org/10.1038/s41467-021-26280-1

Files and links (2)

pdf

Mendelian.pdfDownload View

Published (Version of Record) Open Access

url

Free to Read *No subscription requiredView

Abstract

Parkinson’s disease is a neurodegenerative movement disorder that currently has no disease-modifying treatment, partly owing to inefficiencies in drug target identification and validation. We use Mendelian randomization to investigate over 3,000 genes that encode druggable proteins and predict their efficacy as drug targets for Parkinson’s disease. We use expression and protein quantitative trait loci to mimic exposure to medications, and we examine the causal effect on Parkinson’s disease risk (in two large cohorts), age at onset and progression. We propose 23 drug-targeting mechanisms for Parkinson’s disease, including four possible drug repurposing opportunities and two drugs which may increase Parkinson’s disease risk. Of these, we put forward six drug targets with the strongest Mendelian randomization evidence. There is remarkably little overlap between our drug targets to reduce Parkinson’s disease risk versus progression, suggesting different molecular mechanisms. Drugs with genetic support are considerably more likely to succeed in clinical trials, and we provide compelling genetic evidence and an analysis pipeline to prioritise Parkinson’s disease drug development.

Details

Title: Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Authors/Creators: C.S. Storm (Author/Creator) - UCL Institute of Neurology
D.A. Kia (Author/Creator) - UCL Institute of Neurology
M.M. Almramhi (Author/Creator) - UCL Institute of Neurology
S. Bandrés-Ciga (Author/Creator) - National Institute on Aging
C. Finan (Author/Creator) - University College London
A.J. Noyce (Author/Creator)
R. Kaiyrzhanov (Author/Creator)
B. Middlehurst (Author/Creator)
M. Tan (Author/Creator)
H. Houlden (Author/Creator)
H.R. Morris (Author/Creator)
H. Plun-Favreau (Author/Creator)
P. Holmans (Author/Creator)
J. Hardy (Author/Creator)
D. Trabzuni (Author/Creator)
J. Quinn (Author/Creator)
V. Bubb (Author/Creator)
K.Y. Mok (Author/Creator)
K.J. Kinghorn (Author/Creator)
P. Lewis (Author/Creator)
S.R. Schreglmann (Author/Creator)
R. Lovering (Author/Creator)
L. R’Bibo (Author/Creator)
C. Manzoni (Author/Creator)
M. Rizig (Author/Creator)
M. Ryten (Author/Creator)
S. Guelfi (Author/Creator)
V. Escott-Price (Author/Creator)
V. Chelban (Author/Creator)
T. Foltynie (Author/Creator)
N. Williams (Author/Creator)
K.E. Morrison (Author/Creator)
C. Clarke (Author/Creator)
K. Harvey (Author/Creator)
B.M. Jacobs (Author/Creator)
A. Brice (Author/Creator)
F. Danjou (Author/Creator)
S. Lesage (Author/Creator)
J-C Corvol (Author/Creator)
M. Martinez (Author/Creator)
C. Schulte (Author/Creator)
K. Brockmann (Author/Creator)
J. Simón-Sánchez (Author/Creator)
P. Heutink (Author/Creator)
P. Rizzu (Author/Creator)
M. Sharma (Author/Creator)
T. Gasser (Author/Creator)
S.A. Schneider (Author/Creator)
M.R. Cookson (Author/Creator)
C. Blauwendraat (Author/Creator)
D.W. Craig (Author/Creator)
K. Billingsley (Author/Creator)
M.B. Makarious (Author/Creator)
D.P. Narendra (Author/Creator)
F. Faghri (Author/Creator)
J.R. Gibbs (Author/Creator)
D.G. Hernandez (Author/Creator)
K. Van Keuren-Jensen (Author/Creator)
J.M. Shulman (Author/Creator)
H. Iwaki (Author/Creator)
H.L. Leonard (Author/Creator)
M.A. Nalls (Author/Creator)
L. Robak (Author/Creator)
J. Bras (Author/Creator)
R. Guerreiro (Author/Creator)
S. Lubbe (Author/Creator)
T. Troycoco (Author/Creator)
S. Finkbeiner (Author/Creator)
N.E. Mencacci (Author/Creator)
C. Lungu (Author/Creator)
A.B. Singleton (Author/Creator)
S.W. Scholz (Author/Creator)
X. Reed (Author/Creator)
R.J. Uitti (Author/Creator)
O.A. Ross (Author/Creator)
F.P. Grenn (Author/Creator)
A. Moore (Author/Creator)
R.N. Alcalay (Author/Creator)
Z.K. Wszolek (Author/Creator)
Z. Gan-Or (Author/Creator)
G.A. Rouleau (Author/Creator)
L. Krohn (Author/Creator)
K. Mufti (Author/Creator)
J.J. van Hilten (Author/Creator)
J. Marinus (Author/Creator)
A.D. Adarmes-Gómez (Author/Creator)
M. Aguilar (Author/Creator)
I. Alvarez (Author/Creator)
V. Alvarez (Author/Creator)
F.J. Barrero (Author/Creator)
J.A.B. Yarza (Author/Creator)
I. Bernal-Bernal (Author/Creator)
M. Blazquez (Author/Creator)
M. Bonilla-Toribio (Author/Creator)
J.A. Botía (Author/Creator)
M.T. Boungiorno (Author/Creator)
D. Buiza-Rueda (Author/Creator)
A. Cámara (Author/Creator)
F. Carrillo (Author/Creator)
M. Carrión-Claro (Author/Creator)
D. Cerdan (Author/Creator)
J. Clarimón (Author/Creator)
Y. Compta (Author/Creator)
M. Diez-Fairen (Author/Creator)
O. Dols-Icardo (Author/Creator)
J. Duarte (Author/Creator)
R. Duran (Author/Creator)
F. Escamilla-Sevilla (Author/Creator)
M. Ezquerra (Author/Creator)
C. Feliz (Author/Creator)
M. Fernández (Author/Creator)
R. Fernández-Santiago (Author/Creator)
C. Garcia (Author/Creator)
P. García-Ruiz (Author/Creator)
P. Gómez-Garre (Author/Creator)
M.J.G. Heredia (Author/Creator)
I. Gonzalez-Aramburu (Author/Creator)
A.G. Pagola (Author/Creator)
J. Hoenicka (Author/Creator)
J. Infante (Author/Creator)
S. Jesús (Author/Creator)
A. Jimenez-Escrig (Author/Creator)
J. Kulisevsky (Author/Creator)
M.A. Labrador-Espinosa (Author/Creator)
J.L. Lopez-Sendon (Author/Creator)
A.L. de Munain Arregui (Author/Creator)
D. Macias (Author/Creator)
I.M. Torres (Author/Creator)
J. Marín (Author/Creator)
M.J. Marti (Author/Creator)
J.C. Martínez-Castrillo (Author/Creator)
C. Méndez-del-Barrio (Author/Creator)
M.M. González (Author/Creator)
M. Mata (Author/Creator)
A. Mínguez (Author/Creator)
P. Mir (Author/Creator)
E.M. Rezola (Author/Creator)
E. Muñoz (Author/Creator)
J. Pagonabarraga (Author/Creator)
P. Pastor (Author/Creator)
F.P. Errazquin (Author/Creator)
T. Periñán-Tocino (Author/Creator)
J. Ruiz-Martínez (Author/Creator)
C. Ruz (Author/Creator)
A.S. Rodriguez (Author/Creator)
M. Sierra (Author/Creator)
E. Suarez-Sanmartin (Author/Creator)
C. Tabernero (Author/Creator)
J.P. Tartari (Author/Creator)
C. Tejera-Parrado (Author/Creator)
E. Tolosa (Author/Creator)
F. Valldeoriola (Author/Creator)
L. Vargas-González (Author/Creator)
L. Vela (Author/Creator)
F. Vives (Author/Creator)
A. Zimprich (Author/Creator)
L. Pihlstrom (Author/Creator)
M. Toft (Author/Creator)
P. Taba (Author/Creator)
S. Kõks (Author/Creator)
S. Hassin-Baer (Author/Creator)
K. Majamaa (Author/Creator)
A. Siitonen (Author/Creator)
P. Tienari (Author/Creator)
N.U. Okubadejo (Author/Creator)
O.O. Ojo (Author/Creator)
C. Shashkin (Author/Creator)
N. Zharkinbekova (Author/Creator)
V. Akhmetzhanov (Author/Creator)
G. Kaishybayeva (Author/Creator)
A. Karimova (Author/Creator)
T. Khaibullin (Author/Creator)
T.L. Lynch (Author/Creator)
A.D. Hingorani (Author/Creator)
N.W. Wood (Author/Creator)
Publication Details: Nature Communications, Vol.12(1), Art. 7342
Publisher: Springer Nature
Identifiers: 991005543266107891
Copyright: © 2021 The Authors.
Murdoch Affiliation: Centre for Molecular Medicine and Innovative Therapeutics
Language: English
Resource Type: Journal article
Additional Information: Sulev Koks appears courtesy of the International Parkinson’s Disease Genomics Consortium (IPDGC)

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

70 File views/ downloads

67 Record Views

159 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.189 Genome Studies; 1.189.455 Genome-Wide Association Studies
Web Of Science research areas: Genetics & Heredity
ESI research areas: Molecular Biology & Genetics